Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Markets
Stocks
Sectors
Investing Tools
Overview
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
VICAL (NQ: VICL)
+0.00 (0.00%)
at
2.890
352,394 in Volume
Add to:
My Watchlist
Data as of 08:10 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 3.000
Bid (Size) 2.860 (200)
Ask (Size) 3.140 (200)
Prev. Close 2.890
Today's Range 2.870 - 3.010
52wk Range 1.380 - 5.510
Shares Outstanding 51,813,315
Morningstar Profile
View Full Profile
VICAL
The Company is engaged in the research and development of biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Healthcare
Biotechnology
Exchange Traded NQ
Market Cap 149.74M
Related Companies CRIS PPHM VLS
Featured News
Read More
The following is an investment opinion release issued by Pennystockchaser.com
Jun 30, 2009
from PRNewsWire News Releases
Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
Dec 11, 2008
from PRNewsWire News Releases
Featured News
Read More
SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
Dec 09, 2008
from PRNewsWire News Releases
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
Dec 03, 2008
from PRNewsWire News Releases
Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
Dec 01, 2008
from PRNewsWire News Releases
Vical Announces Strategic Restructuring and Staff Reduction
Nov 21, 2008
from PRNewsWire News Releases
More News
Read More
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA